Angie Drakulich
This is the bio for Angie Drakulich, managing editor of Pharmaceutical Technology magazine.
Angie Drakulich
Editorial Director
732.346.3038, adrakulich@advanstar.com
Angie Drakulich joined Pharmaceutical Technology in 2007, and served as Managing Editor between 2007 and 2011 before becoming Editorial Director. She previously worked at the United Nations Association of the USA as Managing Editor and Assistant Communications Director. Angie has worked an editor, writer, and researcher for Grunar & Jahr USA, Time Inc., and Rodale publishing. She holds a Master of Arts from Seton Hall University’s John C. Whitehead School of Diplomacy and International Relations and a bachelor’s degree from James Madison University.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
